MedTrace Logo

Effect of Pelvic Floor Down-training on Women With Idiopathic Overactive Bladder

NCT06662565 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2024-10-29

No results posted yet for this study

Summary

This study will be conducted to investigate the effect of pelvic floor down-training on women with idiopathic overactive bladder

Conditions

Interventions

BEHAVIORAL

Behavioral modification

It includes: .- Reducing or eliminating smoking and carbonated drinks. * Weight loss in overweight or obese individuals. * Caffeine Reduction: Limiting caffeine intake, especially for those consuming at least 400 mg per day. * Consume Adequate Water: 6 to 8 glasses of water per day. * Refrain from consuming fluids 2 to 3 hours before bedtime. * Identify Bladder Irritants: such as sugar substitutes, citrus fruits, and tomato. * Increasing fiber intake like fruits, and vegetables to reduce constipation with adequate hydration to make stools softer and easier to pass

OTHER

Pelvic floor down-training

Pelvic floor down training exercises aimed at promoting relaxation and deconditioning of the pelvic floor muscles (PFM). It will be practiced three sessions per week for 8 weeks. Biofeedback-Assisted pelvic floor down-training: Procedure: * Rectal biofeedback will be inserted. * The therapist asks the woman to focus on consciously relaxing and releasing the PFM after each contraction or exercise while watching biofeedback screen. * Then, breathe deeply and fully into her abdomen, allowing her pelvic floor to naturally relax and lengthen. * And to incorporate relaxation techniques such as visualization, or progressive muscle relaxation to promote overall muscle relaxation and reduce PFM tension. * Exercises are typically repeated around 10-20 times per session. This number can vary depending on the patient's condition and tolerance, as well as the therapist's assessment and treatment plan.

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Amira N. Abdel Latif, PHD · Cairo University

  • Doaa A. Osman, professor · Cairo University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-10-31
Primary Completion
2025-03-01
Completion
2025-03-15

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06662565 on ClinicalTrials.gov